The active component in Actovegin is extracted and deproteinized from the blood of young calves before being used in human medicine. Because it is fully natural and does not include any synthetic contaminants, it is incorporated into metabolic processes within minutes of being administered into the patient’s body.
In addition to being active transporters of glucose and oxygen, the protein compounds found in Actovegin are also important energy sources for every cell in the body, and much more so for the rapidly growing tissues and organs of the foetus, since they serve as the organism’s primary sources of energy.
Why is Actovegin prescribed during pregnancy and how to use it correctly? Actovegin enhances tissue resilience to nutrition deprivation, hence reducing the risk of tissue damage and mortality. Within 3 hours of taking this medication, the brain cells that are most susceptible to a shortage of oxygen return to their usual state of function.
Tissue division and growth that have been compromised by inadequate blood supply are restored, the number of blood vessels supplying the organs rises, the job of the heart is improved, and muscle mass increases. For the foetus to develop normally, this is critical for the development of all of its organs. As a consequence, Actovegin provides the baby with a better chance of being born physically and cognitively sound than otherwise.
Is Actovegin a prescription medication?
Actovegin is a medication that is recommended for problematic pregnancies, generally after 16 weeks of pregnancy. The following are indications for its use:
The presence of severe somatic disorders in a pregnant woman that occurred before or during pregnancy and caused a shortage in oxygen and nutrients in both the mother and the baby. Diabetes mellitus, congenital or acquired cardiac abnormalities, rheumatism and other systemic disorders of the connective tissue, and arterial hypertension are some of the conditions that fall under this category.
During pregnancy, there may be complications that result in inadequate growth of the placenta or reduced blood flow through it. When the placenta is underdeveloped (hypoplasia) or partially detached, it is accompanied by vasoconstriction during the pregnancy, severe immunological Rh or group conflict between the mother and the foetus, and as a result of this, there is a marked increase in swelling and compression of the placenta’s vessels.
There is a danger of termination of pregnancy, which is accompanied by prolonged or frequent contractions of the muscles of the uterus, which disrupts the blood flow in the placenta’s arteries and the proper growth of the placenta.